openai3 min read
OpenAI acquires Orchestra Bio
OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.
By OpenAI News

Read the full story
Originally published by OpenAI News on Oct 20, 2026.
Comments
Sign in to join the discussion.